Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause a hypercoagulable state that can complicate the management of patients presenting with acute myocardial infarction (MI). We present the case of a patient with coronavirus disease 2019 (COVID-19) with ST elevation MI who was treated with percutaneous coronary intervention and stenting to the left circumflex artery. He was treated appropriately with anticoagulation with appropriate activated clotting time. However, the coronary angiogram course was complicated with heavy thrombosis that involved the left circumflex artery and the left anterior descending artery. Physicians are urged to suspect heparin resistance in COVID-19 patients, particularly if those patients have venous thromboembolism or acute coronary syndrome while taking heparin.
【저자키워드】 COVID-19, Cardiac arrest, STEMI, ACS, 【초록키워드】 coronavirus disease, SARS-CoV-2, coronavirus, anticoagulation, thrombosis, Venous Thromboembolism, management, Patient, Activated clotting time, COVID-19 patients, Acute myocardial infarction, hypercoagulable, Percutaneous coronary intervention, acute respiratory syndrome, physician, Course, involved, treated, presenting, circumflex, complicate, coronary syndrome, descending, 【제목키워드】 Artery, Occlusion, placement, left, Restenosis, Stent,